About the Cancer Epidemiology, Population Health, Access & Policy Session
This session addresses the distribution, determinants, and burden of cancer across populations and examines how healthcare systems, social factors, policies, and access to services influence cancer outcomes. It provides a platform for understanding patterns of cancer incidence and mortality while exploring strategies to improve prevention, diagnosis, treatment access, and equitable cancer care.
Abstract Scope and Participation
Submissions may address cancer epidemiology, risk factors, population health, disparities, health equity, access to cancer services, healthcare delivery, economics, policy, global oncology, and population-based interventions. Participation is encouraged from epidemiologists, clinicians, public-health researchers, policymakers, health economists, and cancer-care professionals.
Topics Covered in Cancer Epidemiology, Population Health, Access & Policy
Topic 01
Cancer Epidemiology
Topic 02
Cancer Risk Factors
Topic 03
Population Health
Topic 04
Health Disparities
Topic 05
Cancer Care Access
Topic 06
Cancer Policy
Featured Speakers — Cancer Epidemiology, Population Health, Access & Policy 2027
Recent Research Presented at Cancer Epidemiology, Population Health, Access & Policy Sessions
Human papillomavirus prevalence and genotype distribution among cervical cancer susceptible women of North Indian ethnicity in Gardasil vaccination era: Public health impact
Objectives : Human papillomavirus (HPV) is the major etiological agent of cervical cancer, a leading cause of morbidity and mortality in women worldwide; screening strategies for reducing the burden…
Geospatial variation and assessment of factors with incidence of colorectal cancer at small area
Background : Examining spatial distribution of colorectal cancer (CRC) incidence or mortality is helpful for developing cancer control and prevention programs, or for generating hypotheses. Such an…
Horizontal comparison of the trend of pancreatic cancer in China and abroad: Lower development correlates with reduced pancreatic cancer burden, defying SDI-based predictions
Pancreatic cancer (PC), characterized by aggressive progression and poor prognosis, poses a critical global health challenge. This multinational study investigates epidemiological disparities in PC…
Community health workers role in advancing cervical cancer prevention and HPV vaccination in Mukono district, Uganda
Cervical cancer remains a significant public health challenge in Africa, with the continent bearing approximately 19% of global cases. The East African region reports particularly concerning…
Related Scientific Sessions at CIOC 2027
Why Attend the Cancer Epidemiology, Population Health, Access & Policy Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Cancer Epidemiology, Population Health, Access & Policy work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Cancer Epidemiology, Population Health, Access & Policy research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Cancer Epidemiology, Population Health, Access & Policy track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Cancer Epidemiology, Population Health, Access & Policy Conference 2027 — FAQs
What is the Cancer Epidemiology, Population Health, Access & Policy track at CIOC 2027?
The Cancer Epidemiology, Population Health, Access & Policy track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Cancer Epidemiology, Population Health, Access & Policy. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Cancer Epidemiology, Population Health, Access & Policy sessions?
Cancer researchers and clinicians, educators and students with an interest in Cancer Epidemiology, Population Health, Access & Policy are all welcome — whether presenting or attending.
Can I present my research in the Cancer Epidemiology, Population Health, Access & Policy track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Cancer Epidemiology, Population Health, Access & Policy sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Cancer Epidemiology, Population Health, Access & Policy track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Register as Delegate →
Attend without presenting.